3005 – ELIMINATION OF RUNX1 MUTANT PRE-LEUKEMIC CLONES IN THERAPY-RELATED MYELODYSPLASTIC SYNDROME
Sign Up to like & getrecommendations! Published in 2020 at "Experimental Hematology"
DOI: 10.1016/j.exphem.2020.09.027
Abstract: Therapy-related Myelodysplastic Syndrome (t-MDS) accounts for up to 20% of all MDS cases and its prevalence is expected to grow as more cancer patients survive. Unfortunately, the prognosis for t-MDS remains poor with 5-year overall… read more here.
Keywords: related myelodysplastic; elimination runx1; 3005 elimination; myelodysplastic syndrome ... See more keywords
Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?
Sign Up to like & getrecommendations! Published in 2017 at "Leukemia"
DOI: 10.1038/leu.2017.238
Abstract: Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse? read more here.
Keywords: therapy related; myelodysplastic syndromes; risk stratification; specific risk ... See more keywords
A Pediatric Case of Treatment-related Myelodysplastic Syndrome While on Therapy for Pre-B Acute Lymphoblastic Leukemia
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Pediatric Hematology/Oncology"
DOI: 10.1097/mph.0000000000002613
Abstract: Background: Treatment-related myelodysplastic syndrome (t-MDS) is a rare late effect of cancer therapy. After alkylating agents, this typically occurs years after completion of therapy. Treatment of t-MDS in pediatrics is an allogeneic stem cell transplant,… read more here.
Keywords: pre acute; therapy; related myelodysplastic; treatment related ... See more keywords
Impact of the type of first-cancer therapy in therapy-related myelodysplastic syndromes outcomes.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e18555
Abstract: e18555Background: Therapy-related myelodysplastic syndromes (t-MDS) are known to have poor outcomes. The impact of the therapy received for the first cancer remains unknown. Methods: 228 t-MDS diag... read more here.
Keywords: therapy related; myelodysplastic syndromes; first cancer; therapy ... See more keywords